The diagnostic value of leptin in progression of GOLD III COPD in patients with excessive body weight

M. Ostrovskyy (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine)

Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Session: Environmental and lifestyle impacts on chronic lung disease
Session type: E-poster
Number: 2329

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine). The diagnostic value of leptin in progression of GOLD III COPD in patients with excessive body weight. 2329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dynamics of marker of inflammation - sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients.
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Inflammatory markers in skeletal muscle of low and normal weight COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


Association between comorbidities, disease severity and body mass index in COPD patients
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Association of weight loss in COPD patients with low body mass index on outcomes
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011

The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients?
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011

The combination of low fat-free mass and high fat mass is related to functional outcome and systemic inflammation in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


BMI is reduced in COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020

Can leptin and IL-6 influence the nutritional status in COPD patients?
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006


Body composition by bioelectrical impedance predicts mortality in COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


The relation of body mass index to survival and respiratory function in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005

Cytokines and weight gain in underweight patients with advanced pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

Ultrasound measurement of quadriceps wasting in patients with GOLD stage II COPD and its relationship to physical activity
Source: Annual Congress 2011 - Innovative methods in clinical physiology
Year: 2011

The relationship between weight loss, lung hyperinflation, adinopectin, ghrelin and leptin levels in COPD patients
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010


Influence of body weight and fat mass on pulmonary function and performance status of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003

Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013

Does body height reduction influence interpretation of lung function in COPD patients?
Source: Eur Respir J 2010; 36: 540-548
Year: 2010



The value of the body composition analysis on COPD patients in different groups according to BMI
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006

Clinical differences of normal weight, over weight and obese asthma patients
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019